Document Detail

Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.
MedLine Citation:
PMID:  23077077     Owner:  NLM     Status:  Publisher    
Mitral valvular disease is strongly related to atrial fibrillation (AF), but the different types of mitral valvular disease have a different prevalence of AF. In this study we explored the expressions of the circulating and local renin-angiotensin-aldosterone system (RAAS) in order to determine the relationship between circulating and local RAAS expressions and its effects on AF in different types of mitral valvular disease patients. Our study group consisted of 24 mitral valvular disease patients scheduled for mitral valve replacement surgery. Peripheral blood samples and left atrial appendage tissue samples were obtained from all patients. Radioimmunoassay was performed to assess the expression levels of circulating and local renin, angiotensin II and aldosterone. In mitral valvular diseases, linear correlation analyses were done for local and circulating renin, angiotensin II and aldosterone; the p values were 0.979, 0.518 and 0.125, respectively. Expression levels of local angiotensin II, circulating angiotensin II and local aldosterone were significantly increased in the AF group compared with sinus rhythm; the p values were 0.023, 0.042 and 0.035, respectively. In mitral stenosis patients, AF was primarily associated with local angiotensin II (p=0.010), as well as being associated with circulating angiotensin II (p=0.038). In mitral regurgitation patients, AF was only significantly associated with local angiotensin II (p=0.038). Circulating and local RAAS expressions are associated with AF in mitral valvular disease patients. The levels of circulating and local RAAS expressions were different in AF patients with different types of mitral valvular diseases. The differentiation of circulating and local RAAS expression levels in AF patients between different types of mitral valvular disease can potentially improve the specific pharmacological interventions outcomes for these patients.
Qian Yongjun; Liu Ying; Tang Hong; Zhou Wenxia; Jiang Lu; Li Yongbo; Li Ning; Li Mei; Xiao Xijun
Related Documents :
23495547 - B-type natriuretic peptide in the cardiology department.
3825577 - Immunoglobulin and c3 abnormalities in acute psychiatric disorders.
21059247 - Identification of novel biomarker candidates by proteomic analysis of cerebrospinal flu...
23685707 - Lessons from radiofrequency redo-procedure after cryoballoon pulmonary vein isolation f...
9174517 - Urine ketone dip test as a screen for ketonemia in diabetic ketoacidosis and ketosis in...
22032627 - Halo nevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-16
Journal Detail:
Title:  Journal of the renin-angiotensin-aldosterone system : JRAAS     Volume:  -     ISSN:  1752-8976     ISO Abbreviation:  J Renin Angiotensin Aldosterone Syst     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100971636     Medline TA:  J Renin Angiotensin Aldosterone Syst     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1Division of Thoracic and Cardiovascular Surgery, West China Hospital, Sichuan University, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adiponectin Deficit During the Precarious Glucose Economy of Early Lactation in Dairy Cows.
Next Document:  Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricul...